Cargando…
Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials
OBJECTIVES: To report the results of a survey conducted among Mayo Clinic medical oncologists, hematologists, and cancer prevention specialists to better understand the current practice of determining whether an adverse event that a patient experience in a clinical trial is related to the drug under...
Autores principales: | Le-Rademacher, Jennifer G., Storrick, Elizabeth M., Jatoi, Aminah, Mandrekar, Sumithra J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543498/ https://www.ncbi.nlm.nih.gov/pubmed/31193907 http://dx.doi.org/10.1016/j.mayocpiqo.2019.01.002 |
Ejemplares similares
-
Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
por: Le-Rademacher, Jennifer G., et al.
Publicado: (2020) -
Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss
por: Le‐Rademacher, Jennifer G., et al.
Publicado: (2019) -
Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients
por: Le‐Rademacher, Jennifer, et al.
Publicado: (2020) -
Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded study
por: Wieland, Jana, et al.
Publicado: (2022) -
Numbers Have Life: A Commentary on “Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit”
por: Le‐Rademacher, Jennifer G., et al.
Publicado: (2019)